Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
66.6 USD | +0.99% | -2.80% | -19.58% |
Apr. 29 | Barclays Adjusts Price Target on Gilead Sciences to $76 From $80 | MT |
Apr. 26 | TD Cowen Adjusts Price Target on Gilead Sciences to $85 From $90 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.58% | 82.23B | |
+33.73% | 664B | |
+29.29% | 567B | |
-7.57% | 354B | |
+18.45% | 330B | |
+4.81% | 286B | |
+13.79% | 234B | |
+4.93% | 199B | |
-9.78% | 196B | |
-4.38% | 148B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- UBS Adjusts Gilead Sciences Price Target to $75 From $81, Maintains Neutral Rating